914 J ournal of Natural Products, 2002, Vol. 65, No. 6
Santangelo et al.
m), 1.61-1.47 (6H, m), 1.39-1.32 (14H, m), 0.88 (3H, t, J )
7.1 Hz, CH3); 13C NMR (CDCl3, 100 MHz) δ 143.33 (C-12),
109.81 (C-11), 98.85 (OCHO), 88.65 (C-9), 79.20 (C-10), 67.66
(C-1), 62.34 (C-5′), 32.66 (C-13), 30.98 (C-14), 30.79, 29.75,
29.37, 29.12, 28.87 (2C), 26.22 (C-4′), 25.52 (C-3), 22.16 (C-
15), 19.71 (C-3′), 19.35 (C-8), 13.89 (CH3); EIMS m/z 320 [M]+
(5), 249 (11), 122 (19), 121 (12), 95 (9), 91 (15), 85 (100), 79
(29), 78 (14), 77 (20), 67 (16), 57 (21), 56 (20), 55 (19), 43 (18),
41 (13).
Dicycloh exylbor a n e. The temperature was kept between
-5 and -10 °C, while a solution of borane in tetrahydrofuran
(1 M, 3.1 mL, 3.1 mmol) was added slowly over a period of 30
min to a solution of cyclohexene (0.51 g, 6.2 mmol) in THF (3
mL). The resultant milky solution was stirred at 0 to -10 °C
for 2 h and then used as such in the next step.
1-(Tetr a h yd r o-2-p yr a n yloxy)-(9Z,11E)-h exa d eca d ien e
(18). A solution of compound 17 (0.45 g, 1.4 mmol) in THF
(2.5 mL) was added dropwise to the above dicyclohexylborane
solution (3.1 mmol) at -20 °C. The suspension was stirred at
approximately -15 °C for 2 h and then allowed to reach room
temperature. After 2 h of stirring at room temperature the
precipitate of dicyclohexylborane had disappeared. Glacial
acetic acid (1.3 mL) was then added to the mixture, which was
stirred overnight at 45 °C. Oxidation of the resulting dicyclo-
hexylborinate was achieved by addition of sodium hydroxide
(6 M, 5 mL) followed by dropwise addition of hydrogen peroxide
(35%, 1.4 mL) at a rate maintaining the reaction mixture at
30-35 °C. The mixture was stirred for an additional 30 min
and was then poured into ice-water (15 mL), extracted with
hexane (4 × 30 mL), dried (MgSO4), and chromatographed,
providing the desired compound 18 in 65% yield: 1H NMR
(CDCl3, 400 MHz) δ 6.31-6.25 (1H, m, H-11), 5.92 (1H, t, J )
10.9 Hz, H-10), 5.64 (1H, dt, J ) 15 Hz, J ) 7.2 Hz, H-12),
5.34-5.24 (1H, m, H-9), 4.56 (1H, bs, OCHO), 3.86 (1H, ddd,
J ) 11.0 Hz, J ) 7.7 Hz, J ) 3.4 Hz, Haxial-5′), 3.71, 3.36 (each
65 (8), 57 (16), 55 (7), 53 (15), 44 (64), 44 (36), 42 (26), 41 (100),
39 (15), 32 (19); HREIMS m/z 236.220520 (calcd for C16H28O,
236.214016).
1-(Tetr a h yd r o-2-p yr a n yloxy)-(Z)-h exa d ec-11-en -9-yn e
(20). Compound 20 was prepared, from the aldehyde 16, in
the same manner as compound 14 was prepared from com-
pound 11. The product obtained was a 62% yield of a mixture
containing 20:1 Z-20 and E-17: 1H NMR (CDCl3, 400 MHz)
of 20 δ 5.78 (1H, dt, J ) 10.7 Hz, J ) 7.3 Hz, H-12), 5.40 (1H,
bd, J ) 10.7 Hz, H-11), 4.55 (1H, dd, J ) 4.4 Hz, J ) 2.4 Hz,
OCHO), 3.87-3.82 (1H, m, Haxial-5′), 3.70, 3.35 (each 1H, dt,
J ) 9.7 Hz, J ) 6.7 Hz, H-1), 3.50-3.45 (1H, m, Hequat-5′), 2.32
(2H, td, J ) 7.0 Hz, J ) 1.8 Hz, H-8), 2.26 (2H, td, J ) 7.2 Hz,
J ) 1.2 Hz, H-13), 1.84-1.76 (1H, m), 1.68 (1H, m), 1.6-1.45
(6H, m), 1.4-1.3 (14H, m), 0.88 (3H, t, J ) 6.7 Hz, CH3); 13C
NMR (CDCl3, 100 MHz) δ 142.58 (C-12), 109.26 (C-11), 98.80
(OCHO), 94.36 (C-9), 79.10 (C-10), 67.62 (C-1), 62.31 (C-5′),
31.01 (C-14), 30.74, 29.71, 29.68, 29.36, 29.07, 28.81, 28.78 (C-
13), 26.18 (C-4′), 25.46 (C-3), 22.2 (C-15), 19.67 (C-3′), 19.47
(C-8), 13.89 (CH3); EIMS m/z 320 [M]+ (7), 122 (11), 121 (6),
119 (9), 95 (9), 93 (10), 91 (21), 85 (100), 81 (10), 80 (11), 79
(33), 78 (12), 77 (15), 67 (21), 65 (6), 57 (13), 56 (12), 55 (22),
43 (16), 41 (55), 39 (7).
1-(Tetr a h yd r o-2-p yr a n yloxy)-(9Z,11Z)-h exa d eca d ien e
(21). Compound 21 was prepared from compound 20, as
described before for the preparation of compound 18 from 17,
and in 65% yield: 1H NMR (CDCl3, 400 MHz) δ 6.21 (2H, bd,
J ) 9.5 Hz, H-10 and H-11), 5.40 (2H, bq, J ) 6.6 Hz, H-10
and H-11), 4.54 (1H, t, J ) 2.7 Hz, OCHO), 3.83 (1H, ddd, J )
11.1 Hz, J ) 7.6 Hz, J ) 3.3 Hz, Haxial-5′), 3.69, 3.35 (each 1H,
dt, J ) 9.4 Hz, J ) 7.0 Hz, H-1), 3.43-3.49 (1H, m, Hequat-5′),
2.16-2.10 (2H, m, H-8 or H-13), 1.98-1.91 (2H, m, H-8 or
H-13), 1.83-1.75 (1H, m), 1.71-1.64 (1H, m), 1.59-1.45 (6H,
m), 1.35-1.25 (14H, bs), 0.88 (3H, t, J ) 6.7 Hz, CH3); 13C
NMR (CDCl3, 100 MHz) δ 131.9 (C-9 and C-12), 123.56 (C-10
and C-11), 98.74 (C-1′), 67.59 (C-1), 62.20 (C-5′), 31.76 (C-14),
30.73 (C-3′), 29.71, 29.58, 29.53, 29.38, 29.17, 28.92, 27.40 (C-8
or C-13), 27.13 (C-8 or C-13), 26.19 (C-4′), 25.48 (C-3), 19.63
(C-3′), 13.86 (CH3); EIMS m/z 322 [M]+ (2), 238 (4), 135 (4),
109 (8), 95 (7), 85 (100), 81 (19), 78 (14), 67 (44), 55 (17), 54
(23), 41 (14), 41 (58).
(9Z,11Z)-Hexa d eca d ien -1-ol (22). The compound 21 was
deprotected, in 97% yield, to the alcohol 22 by the method used
to prepare compound 13 from 12: 1H NMR (CDCl3, 400 MHz)
δ 6.22 (2H, bd, J ) 9.8 Hz, H-10 and H-11), 5.41 (2H, bq, J )
7.8 Hz, H-9 and H-12), 3.60 (2H, t, J ) 6.6 Hz, H-1), 2.18-
2.11 (4H, m, H-8 and H-13), 1.65 (1H, bs, OH), 1.52 (2H, quint,
J ) 6.7 Hz, H-2), 1.39-1.28 (14H, bs), 0.88 (3H, t, J ) 6.7 Hz,
H-16); 13C NMR (CDCl3, 100 MHz) δ 132.12 (C-9 or C-12),
131.94 (C-9 or C-12), 123.54 (C-10 or C-11), 123.50 (C-10 or
C-11), 62.95 (C-1), 32.71 (C-2), 31.76 (C-14), 29.56, 29.41, 29.33,
29.16, 27.40 (C-8 or C-13), 27.13 (C-8 or C-13), 25.67 (C-3),
22.30 (C-15), 13.91 (CH3); EIMS m/z 238 [M]+ (28), 136 (6),
121 (16), 110 (12), 109 (15), 108 (14), 107 (6), 98 (9), 96 (9), 95
(32), 94 (21), 93 (22), 91 (9), 85 (10), 83 (7), 82 (49), 81 (50), 80
(19), 79 (28), 69 (21), 68 (16), 67 (100), 66 (9), 57 (11), 55 (34),
54 (28), 53 (9), 44 (9), 42 (28).
(9Z,11Z)-Hexa d eca d ien a l (4). The dienol 22 was oxidized
to the dienal 4 by PDC, as described above for the oxidation
of 13 to compound 1, in an isomeric purity of >99% and
71%yield: 1H NMR (CDCl3, 400 MHz) δ 9.75 (1H, t, J ) 1.85
Hz, CHO), 6.23 (2H, bd, J ) 10.0 Hz, H-10 and H-11), 5.42
(2H, bq, J ) 7.8 Hz, H-9 and H-12), 2.40 (2H, td, J ) 7.32 Hz,
J ) 1.86 Hz, H-2), 2.16 (4H, m, H-8 and H-13), 1.61 (2H, quint,
J ) 7.28 Hz, H-3), 1.40-1.24 (12H, m), 0.88 (3H, t, J ) 7.2
Hz, CH3); 13C NMR (CDCl3, 100 MHz) δ 202.92 (CHO), 132.16
(C-9 or C-12), 131.84 (C-9 or C-12), 123.66 (C-10 or C-11),
123.49 (C-10 or C-11), 43.88 (C-2), 31.78 (C-14), 29.50, 29.17,
29.08, 28.99, 27.37 (C-8 or C-13), 27.16 (C-8 or C-13), 22.32
(C-15), 22.03 (C-3), 13.94 (CH3); EIMS m/z 236 [M]+ (34), 151
(11), 148 (10), 137 (11), 135 (10), 124 (12), 123 (15), 121 (13),
111 (10), 110 (15), 109 (18), 107 (13), 98 (19), 97 (11), 96 (32),
95 (48), 94 (16), 93 (19), 91 (16), 83 (10), 82 (25), 81 (62), 80
(17), 79 (20), 77 (12), 68 (20), 68 (24), 67 (100), 55 (37), 54 (36),
1H, dt, J ) 9.6 Hz, J ) 7.0 Hz, H-1), 3.51-3.46 (1H, m, Hequat
-
5′), 2.15 (2H, q, J ) 7.0 Hz, H-8 or H-13), 2.08 (2H, q, J ) 7.0
Hz, H-8 or H-13), 1.85-1.79 (1H, m), 1.73-1.68 (1H, m), 1.59-
1.52 (6H, m), 1.37-1.29 (14H, m), 0.88 (t, J ) 7.0 Hz, 3H); 13
C
NMR (CDCl3, 100 MHz) δ 134.65 (C-9 or C-12), 130.06 (C-9 or
C-12), 128.57 (C-10 or C-11), 125.58 (C-10 or C-11), 98.83 (C-
1′), 67.68 (C-1), 62.34 (C-5′), 32.55 (C-2′ or C-13), 31.55 (C-2′
or C-13), 30.77 (C-14), 29.73, 29.70, 29.44 (2C), 29.20, 27.68
(C-8), 26.21 (C-4′), 25.49 (C-3), 22.27 (C-15), 19.70 (C-3′), 13.94
(CH3).
(9Z,11E)-Hexa d eca d ien -1-ol (19). The alcohol 19 was
prepared from compound 18 in analogy with compound 13 in
97% yield: 1H NMR (CDCl3, 400 MHz) δ 6.30-6.23 (1H, m,
H-11), 5.92 (1H, t, J ) 10.9 Hz, H-10), 5.63 (1H, dt, J ) 15
Hz, J ) 7.0 Hz, H-12), 5.59-5.23 (1H, m, H-9), 3.60 (2H, t, J
) 6.64 Hz, H-1), 2.13 (2H, q, J ) 7.0 Hz, H-13), 2.07 (2H, q, J
) 7.0 Hz, H-8), 2.02 (1H, bs, OH), 1.57-1.50 (2H, m), 1.30-
1.25 (14H, bs), 0.88 (3H, t, J ) 7.0 Hz, CH3); 13C NMR (CDCl3,
100 MHz) δ 134.62 (C-9 or C-12), 129.96 (C-9 or C-12), 128.57
(C-10 or C-11), 125.54 (C-10 or C-11), 62.96 (C-1), 32.72 (C-2),
32.52 (C-13), 31.51 (C-14), 29.66, 29.42, 29.34, 29.13, 27.61 (C-
8), 25.68 (C-3), 22.23 (C-15), 13.90 (CH3); EIMS m/z 238 [M]+
(38), 135 (14), 121 (10), 110 (13), 109 (13), 108 (8), 107 (10), 96
(18), 95 (26), 94 (42), 93 (21), 91 (37), 85 (20), 81 (20), 80 (42),
79 (35), 67 (100), 55 (42), 54 (36), 43 (56), 31 (63).
(9Z,11E)-Hexa d eca d ien a l (3). The dienal 3 was prepared
from compound 19 as described before for the preparation of
compound 1 (from compound 13) in an isomeric purity of
>99% and 71% yield: 1H NMR (CDCl3, 400 MHz) δ 9.75
(1H, t, J ) 1.81 Hz, CHO), 6.31-6.23 (1H, m, H-11), 5.91 (1H,
t, J ) 11 Hz, H-10), 5.61 (1H, dt, J ) 15.0 Hz, J ) 7.0 Hz,
H-12), 5.6-5.23 (1H, m, H-9), 2.40 (2H, td, J ) 7.0 Hz, J )
1.83 Hz, H-2), 2.1 (2H, q, J ) 7.0, H-13 or H-8), 2.01 (2H, q,
J ) 7.0 Hz, H-8 or H-13), 1.31-1.24 (14H, m), 0.88 (3H, J )
7.0 Hz, CH3); 13C NMR (CDCl3, 100 MHz) δ 202.91 (CHO),
134.6 (C-9 or C-12), 129.95 (C-9 or C-12), 128.6 (C-10 or C-11),
43.88 (C-2), 32.5 (C-13), 31.85 (C-14), 29.5, 29.4, 29.3, 29.1,
27.5 (C-8), 22.27 (C-15), 22.01 (C-3), 13.93 (s. CH3); EIMS m/z
236 [M]+ (38), 121 (10), 95 (16), 94 (7), 93 (7), 91 (10), 83 (10),
82 (16), 81 (25), 80 (8), 79 (16), 77 (9), 68 (7), 67 (36), 66 (6),